Impaired TFAM expression promotes mitochondrial damage to drive fibroblast activation and fibrosis in systemic sclerosis.
Xiang ZhouThuong Trinh-MinhCuong Tran-ManhAndreas GießlChristina BergmannAndrea-Hermina GyörfiLarissa Valor-MéndezJörg H W DistlerPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
Alterations in the key mitochondrial transcription factor TFAM in response to prolonged activation of TGFβ and associated mitochondrial damage induce transcriptional programs that promote fibroblast-to-myofibroblast transition and drive tissue fibrosis.